scholarly journals Celiac Disease Risk Determined By HLA-DQ Genotype Protects Against Gvhd in a Dose-Responsive Manner

2020 ◽  
Vol 26 (3) ◽  
pp. S186
Author(s):  
Susan McClory ◽  
Viviane C. Cahen ◽  
Yimei Li ◽  
Jamie L. Duke ◽  
Dimitri S. Monos ◽  
...  
Keyword(s):  
2020 ◽  
Vol 81 (2-3) ◽  
pp. 59-64 ◽  
Author(s):  
Rok Seon Choung ◽  
John R. Mills ◽  
Melissa R. Snyder ◽  
Joseph A. Murray ◽  
Manish J. Gandhi

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Lucas Malta Almeida ◽  
Lenora Gandolfi ◽  
Riccardo Pratesi ◽  
Rosa Harumi Uenishi ◽  
Fernanda Coutinho de Almeida ◽  
...  

Background. Celiac disease (CD) is a genetically determined immune-mediated disorder in which gluten immunogenic peptides are presented to CD4 T cells by HLA-DQ2.5, DQ8, DQ2.2, and their combinations. Our aim is to establish a risk gradient for celiac disease based on HLA-DQ profile in a brazilian representative population and the relevance of DQ2.2 in celiac disease development. Materials and Methods. 237 celiac patients and 237 controls (both groups with 164 females and 73 males) were included. All samples were tested for the presence of predisposing HLA-DQ alleles using the PCR-SSP method. Results were considered significant when p<0.05. Disease risk was expressed as 1 : N for each HLA-DQ category described at this study. Results. DQ2.5 and/or DQ8 were detected in 224 celiac patients (94.5%) and 84 controls (35.4%). Eight celiac patients (3.4%) and 38 controls (16%) disclosed only DQ2.2. Even though DQ2.2 (β2/β2 or β2/x) showed a low CD risk of 1 : 251 and 1 : 550, respectively, the genotype DQ2.5/DQ2.2 (β2/β2) showed high CD risk of 1 : 10 (p<0.0001). The disease risk gradient ranged from 1 : 3014 to 1 : 7. Conclusion. Our study allowed the determination of a risk gradient for celiac disease development in at-risk population, showing that DQ2.2 variant was relevant when associated with DQ2.5.


2011 ◽  
Vol 77 (15) ◽  
pp. 5316-5323 ◽  
Author(s):  
Ester Sánchez ◽  
Giada De Palma ◽  
Amalia Capilla ◽  
Esther Nova ◽  
Tamara Pozo ◽  
...  

ABSTRACTCeliac disease (CD) is an immune-mediated enteropathy involving genetic and environmental factors whose interaction might influence disease risk. The aim of this study was to determine the effects of milk-feeding practices and the HLA-DQ genotype on intestinal colonization ofBacteroidesspecies in infants at risk of CD development. This study included 75 full-term newborns with at least one first-degree relative suffering from CD. Infants were classified according to milk-feeding practice (breast-feeding or formula feeding) and HLA-DQ genotype (high or low genetic risk). Stools were analyzed at 7 days, 1 month, and 4 months by PCR and denaturing gradient gel electrophoresis (DGGE). TheBacteroidesspecies diversity index was higher in formula-fed infants than in breast-fed infants. Breast-fed infants showed a higher prevalence ofBacteroides uniformisat 1 and 4 months of age, while formula-fed infants had a higher prevalence ofB. intestinalisat all sampling times, ofB. caccaeat 7 days and 4 months, and ofB. plebeiusat 4 months. Infants with high genetic risk showed a higher prevalence ofB. vulgatus, while those with low genetic risk showed a higher prevalence ofB. ovatus,B. plebeius, andB. uniformis. Among breast-fed infants, the prevalence ofB. uniformiswas higher in those with low genetic risk than in those with high genetic risk. Among formula-fed infants, the prevalence ofB. ovatusandB. plebeiuswas increased in those with low genetic risk, while the prevalence ofB. vulgatuswas higher in those with high genetic risk. The results indicate that both the type of milk feeding and the HLA-DQ genotype influence the colonization process ofBacteroidesspecies, and possibly the disease risk.


2021 ◽  
Vol 14 ◽  
pp. 117863882110606
Author(s):  
Avinash Lomash ◽  
Anupa Prasad ◽  
Raghvendra Singh ◽  
Somesh Kumar ◽  
Rishi Gupta ◽  
...  

Introduction: Citrulline is regarded as a biomarker for celiac disease (CD). Its utility for assessment and evaluation of additive predictive value for latent, potential CD and first degree relatives (FDRs) needs exploration. Method: Consecutive 558 index cases diagnosed as per European Society for Pediatric Gastroenterology and Nutrition (ESPGHAN) 2012 guidelines and their 1565 FDRs were evaluated over five and half year period. Serology negative FDRs at initial visit and follow ups were served as controls. HLA typing for DQ2 and DQ8 genotypes, along with plasma and dried blood spot (DBS) filter paper citrulline were evaluated. Results: Median plasma citrulline values were 20.1 and 37.33 µMol/l in cases and controls ( P < .001). Cut off values for Marsh grade 3a, 3b, and 3c were 35.0, 32.8, 25.26 µMol/l in CD patients and 36.51, 30.10, 25.26 µMol/l in biopsy proven FDR. Increasing trends of plasma citrulline levels with decreasing tTG-IgA levels were observed on follow up. Low plasma citrulline levels were observed with HLA DQ 2.5 genotype ( P < .05). Agreement between DBS and plasma citrulline was 94.8%. Conclusion: Citrulline is a good surrogate biomarker for identification of histopathological grade of damage, extent of mucosal recovery and has negative correlation with tTG-IgA. It identifies the silent and latent phase of CD. DBS citrulline provides adequate information and can be used for monitoring CD patients at remote locations.


Author(s):  
Alejandra Parada ◽  
Magdalena Araya ◽  
Francisco Pérez-Bravo ◽  
Marco Méndez ◽  
Adriana Mimbacas ◽  
...  

2008 ◽  
Vol 98 (2) ◽  
pp. 337-342 ◽  
Author(s):  
Cecilia Olsson ◽  
Hans Stenlund ◽  
Agneta Hörnell ◽  
Olle Hernell ◽  
Anneli Ivarsson

Helicobacter ◽  
2018 ◽  
Vol 23 (2) ◽  
pp. e12465 ◽  
Author(s):  
Maria P. Dore ◽  
Roberta Salis ◽  
Maria F. Loria ◽  
Vincenzo Villanacci ◽  
Gabrio Bassotti ◽  
...  

2014 ◽  
Vol 46 ◽  
pp. e109
Author(s):  
Silvia Nastasio ◽  
Lorenza Lepore ◽  
Elena Chiocca ◽  
Giulia Marsalli ◽  
Silvia Ghione ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document